Corticosteroids for Hair Loss: When Cortisone Really Helps

Many people search for “cortisone for hair loss” hoping for a remedy that slows down any kind of hair loss. That expectation is often misleading. Glucocorticoids treat inflammation at the hair follicle, not “hair loss in general.” This article explains which causes cortisone actually works on, the forms in which it is used, the side effects it carries and why the diagnosis always belongs in the hands of a dermatologist. Information current as of June 2026, with reference to the current S3 guideline on alopecia areata (AWMF 013-104, published 23 February 2026).

What are glucocorticoids (cortisone, corticosteroids)?

Glucocorticoids (commonly called cortisone) are steroid hormones produced by the adrenal cortex, either occurring naturally in the body or synthetically reproduced. In hair loss, they dampen misdirected immune reactions and inflammation directly at the hair follicle. According to the Gelbe Liste, they have a “pronounced anti-inflammatory and immunosuppressive effect.” They are the anti-inflammatory subgroup of the corticosteroids, and “cortisone” is the everyday umbrella term for this group of active substances.

To clarify the terminology: corticosteroids are the broad term for steroid hormones of the adrenal cortex, while glucocorticoids are the anti-inflammatory subgroup. Synthetic examples include prednisolone, dexamethasone, betamethasone, triamcinolone and clobetasol. In everyday use “cortisone,” “corticosteroids” and “glucocorticoids” are treated as largely interchangeable, which is why this article uses them as synonyms.

How glucocorticoids act on the hair follicle

Glucocorticoids act on the hair follicle by curbing the inflammatory attack of immune cells. They bind intracellularly to glucocorticoid receptors, inhibit pro-inflammatory messenger substances and thereby reduce the reaction against the follicle. According to a review in PMC (PMC5939003), the mechanism of topical corticosteroids consists of “containing the inflammation and accelerating the recovery of damaged hair follicles.”

Crucial for managing expectations: when the immune attack is dampened, the follicle can re-enter the growth phase (anagen) from the resting phase. We explain the logic of the resting and growth phases in detail in our article on the hair cycle. Cortisone therefore treats the inflammation, not a genetic or nutritional cause.

Cortisone for hair loss: when it really helps (and when it does not)

Cortisone for hair loss only helps when the hair loss is caused by inflammation or autoimmunity. In the most common type, hereditary androgenetic hair loss, it is ineffective, because there is no inflammatory process there but rather a genetically driven sensitivity of the follicles to the hormone DHT. Diffuse hair loss caused by iron deficiency, thyroid problems or stress also does not respond to corticosteroids.

If you have hereditary (androgenetic) hair loss, the evidence-based routes are not corticosteroids but minoxidil, finasteride or, with a suitable diagnosis, a hair transplant. Cortisone would find no mechanism to act on here. The dermatological diagnosis determines which type you have.

The most important inflammatory indication is alopecia areata (patchy hair loss). According to the Rochester Epidemiology Project, its lifetime prevalence is around 2.1 percent, meaning roughly two in a hundred people over the course of their lives. In Germany, around 170,000 people are affected according to the S3 guideline (Charité, 2026). The table below classifies the most common types of hair loss.

This distinction is the heart of the matter: corticosteroids for hair loss are highly effective for the right cause and ineffective for the wrong one. If you have diffuse shedding caused by iron deficiency or the thyroid, the cause should be treated, not the follicle dampened with cortisone.

Alopecia areata: the main reason cortisone is prescribed

Alopecia areata (patchy hair loss) is an autoimmune condition in which the immune system attacks the hair follicles. Glucocorticoids are one of the established first-line therapies here. The typical sign is sharply defined, round bald patches. Importantly, the follicles remain intact, which is why the hair loss is generally reversible, unlike with scarring alopecias.

Cortisone dampens the immune attack locally or systemically so that the follicle can recover. The current S3 guideline on alopecia areata (AWMF register 013-104, published 23 February 2026, Charité Berlin) lists topical corticosteroids, intralesional injection and systemic therapy as established treatment strategies with long-standing evidence. The guideline comprises 79 evidence- and consensus-based recommendations.

To be honest about it: in mild forms, spontaneous recovery is common. According to a review (PMC10072216), patients with under 25 percent scalp involvement show spontaneous regression in up to 68 percent of cases, while with more than 50 percent involvement this drops to around 8 percent. More recent placebo-controlled studies, however, estimate spontaneous remission more cautiously. The course is highly variable and should be assessed by a dermatologist.

As a newer alternative for severe alopecia areata, JAK inhibitors such as baricitinib (EU approval 2022) and ritlecitinib (EMA approval 2023) are approved. They are currently not reimbursed by the statutory health insurance in Germany. Whether they are an option is decided solely by the treating dermatologist.

Cortisone ointment, solution and foam (topical glucocorticoids)

Topical glucocorticoids are ointments, solutions or foams containing cortisone that are applied directly to the scalp. They are usually the first step for limited inflammatory hair loss. They are classified by potency into four strength classes (Niedner classification, Germany), from class I (weak, e.g. hydrocortisone) to class IV (very strong, e.g. clobetasol propionate).

In alopecia areata, high-potency active substances are usually used, such as clobetasol propionate 0.05 percent (class IV) or mometasone furoate 0.1 percent (class III). In a study of 34 patients over 12 to 24 weeks, 89 percent responded with regrowth (clobetasol foam, haarerkrankungen.de). Another study with a clobetasol ointment found a satisfactory response in only around 18 percent. The range depends heavily on the severity.

On the common “ointment or solution” question: on the hair-bearing scalp, solutions, foams or tinctures are usually prescribed instead of greasy ointments. They are easier to apply between the hairs and penetrate better. A glucocorticoid ointment in the classic sense is rather impractical on the scalp, but the mechanism of action remains the same.

Local side effects of topical corticosteroids are rare with proper, limited use. With overly long or overly strong use, there is a risk of skin atrophy (skin thinning), telangiectasia (dilated fine blood vessels), steroid acne or pigmentation disorders (PharmaWiki). The scalp, however, is considered a relatively resilient zone with a lower atrophy risk than other parts of the body.

Cortisone injection (intralesional injection)

A cortisone injection for the hair is an intralesional injection, usually with triamcinolone acetonide, directly into the bald patch on the scalp. It is regarded as the standard therapy for limited alopecia areata in adults. A concentration of around 5 mg/ml is common on the scalp, with a guideline maximum of about 20 mg per session (springermedizin.at).

Procedure: the dermatologist makes several small injections per bald area with a fine needle. The sessions are typically repeated every 4 to 6 weeks (PMC3002419), often in a series of three to five appointments. The injection is usually well tolerated and only mildly stinging. This method cannot be self-administered.

On the effect: a first response typically appears in studies after 4 to 8 weeks (PMC3002419). The response rates vary with the concentration. In clinical studies, hair growth at around 5 mg/ml was approximately 80 percent, lower at lower concentrations. Higher concentrations brought no advantage, only more side effects. If no improvement appears after about 6 months, the therapy is reconsidered.

Local side effects of the cortisone injection are temporary dimples (skin atrophy at the injection site), hypopigmentation (lightening) and telangiectasia. According to the literature (PMC3002419), these usually resolve on their own. It is precisely this targeted, local potency that is the advantage of the injection over ointment treatment alone.

Cortisone tablets (systemic glucocorticoids)

Systemic glucocorticoids (cortisone tablets or infusions) are used only for severe, rapidly progressing or extensive forms, because they affect the entire body. Typical reasons are rapidly progressive or extensive alopecia areata, up to alopecia totalis or universalis. Usually a time-limited burst (pulse therapy) is given, not a long-term therapy.

The effect sets in quickly, but the risk of relapse after stopping is high. In studies, the response rate in multifocal alopecia areata was around 50 percent after 6 months, considerably lower in alopecia totalis or universalis (Karger). This is precisely why doctors carefully weigh the benefit against the side effects.

The systemic side effects must be taken seriously: weight gain and fat redistribution (a Cushing-like picture), elevated blood pressure, elevated blood sugar (up to a fourfold higher diabetes risk according to medicoconsult.de), psychological changes, increased susceptibility to infection and stomach complaints. With prolonged use, osteoporosis and a suppression of the body’s own adrenal function are added.

Contraindications: when cortisone is not used or only with restrictions

Whether cortisone may be used for hair loss is assessed by the doctor on a case-by-case basis, because there are situations in which particular caution or avoidance is warranted. Since all effective corticosteroids are prescription-only, this weighing-up is always done by a doctor. Relevant pre-existing conditions such as poorly controlled diabetes, high blood pressure, osteoporosis, gastrointestinal ulcers or active infections may argue against systemic therapy.

During pregnancy and breastfeeding, a particularly strict benefit-risk assessment applies. The treatment of hair loss, which is cosmetically motivated in any case, then usually takes a back seat, and the doctor decides whether, in what form and at what dose any treatment is given at all. Self-medication with cortisone is not indicated during this time. Which therapy is appropriate should be clarified exclusively with the treating physician.

Use in scarring alopecia and scalp inflammation

In scarring (cicatricial) alopecias such as lichen planopilaris or frontal fibrosing alopecia, cortisone is meant to stop the inflammation before follicles are permanently destroyed. Here lies an important difference from alopecia areata: follicles that are already scarred no longer grow back (universimed.ch). The goal is therefore to stop the progression, not to regenerate hair.

High-potency topical corticosteroids and intralesional triamcinolone injections are used, and in active progression also systemic therapy. Because every new flare of inflammation can irreversibly destroy follicles, an early start of therapy is decisive. Anyone who notices shiny, scarred-looking bald areas with no visible follicle openings should see a dermatologist promptly.

Inflammatory scalp conditions that secondarily promote hair loss are also treated with cortisone. In scalp psoriasis, topical corticosteroids of class III/IV are first-line, often combined with a vitamin D analog. In seborrheic dermatitis, mild corticosteroids together with antifungals are used as the main therapy. Once the underlying condition heals, the accompanying hair loss usually recedes.

Prescription requirement, self-medication and “cortisone without a prescription”

Glucocorticoids for hair loss are prescription-only in any effective strength. This applies to topical corticosteroids of classes II to IV as well as to all intralesional injections and systemic tablets. Only weak hydrocortisone preparations (up to about 0.5 percent) for mild eczema and itching are available over the counter, and these are not intended for hair loss.

“Cortisone for hair loss without a prescription” is therefore not a sensible option. Without a diagnosis, there is a risk of the wrong therapy, of masking the findings and of unnecessary side effects. According to the Pharmazeutische Zeitung, the most important recommendation is therefore: first clarify the cause with a dermatologist, then treat it specifically. A sound diagnosis often begins with the patient history and, if appropriate, a blood test for hair loss.

On the cost question: with a confirmed medical indication, such as diagnosed alopecia areata, topical corticosteroids and intralesional injections are generally covered by the statutory health insurance. JAK inhibitors, by contrast, are currently not reimbursed. The details are clarified by the treating practice.

Cortisone for hair loss: how quickly does it work? (regrowth timeline)

With a responsive, inflammatory cause, cortisone for hair loss shows first effects after weeks, while visible regrowth follows over months in line with the natural hair cycle. A first response to the intralesional injection can be expected after 4 to 8 weeks according to PMC3002419, and after about 6 to 14 weeks with topical use. The following timeline shows the realistic course.

An honest classification is part of the picture: a relapse after stopping is common. After systemic cortisone therapy, alopecia areata recurs in around 60 percent of cases (haarerkrankungen.de, springermedizin.at). This reflects the chronic, relapsing course of the condition, not a failure of the therapy. Cortisone suppresses the immune attack while it is active, but it does not eliminate the autoimmune predisposition.

Can cortisone itself cause hair loss?

Cortisone is used against hair loss, but in rare cases, especially with high-dose long-term use, it can itself contribute to diffuse hair loss. With long-term systemic therapy, metabolic and hormonal effects can trigger a premature transition of follicles into the resting phase, that is, a telogen effluvium (blog.hairsystems-heydecke.de). This shedding is usually reversible.

This is not a contradiction but a distinction: the targeted treatment of an inflammatory cause differs from the unwanted effect of a long, high-dose systemic therapy. With short-term or topical use and a correct indication, this effect is not a relevant problem. If new hair loss occurs during ongoing cortisone therapy, the rule is: talk to the treating doctor, do not stop on your own.

When the hair loss is stable: is a hair transplant an option?

A hair transplant is explicitly not indicated for active inflammatory or autoimmune hair loss. In active alopecia areata it is contraindicated, because the immune system would attack transplanted follicles as well. The same applies to active scarring alopecias as long as the inflammation is progressing. Here dermatological treatment comes first, not a procedure.

Only with a demonstrably stable, burnt-out condition, such as a long-quiescent scarring alopecia after dermatological confirmation of inactivity (often after at least one year of inactivity), can a hair transplant even be considered. The classic transplant case, by contrast, is hereditary androgenetic hair loss, an entirely different, non-inflammatory cause. Often more than one type is even present at the same time.

Which form of hair loss you have, and whether a procedure makes sense at all, is first clarified by the dermatological diagnosis. A non-binding hair analysis at Elithair examines the visual distribution pattern and can help to differentiate the hair type. It does not replace a medical blood test or a dermatological diagnosis of the underlying condition, but is a first, advisory filter.

When you should see a dermatologist about hair loss

Whether cortisone is an option for hair loss depends solely on the diagnosis. The following warning signs point to an inflammatory or autoimmune cause and should be clarified by a dermatologist promptly. With scarring forms, every week counts, because destroyed follicles do not return.

For background on the various triggers, it is worth looking at the causes of hair loss. Women with diffuse thinning will find further context in the article on hair loss in women.

Frequently asked questions about glucocorticoids (cortisone) in hair loss

Sources